Cancer

RSS

Market launch for Trisenox, a new Rx for a severe form of leukemia

Oct. 16, 2000

Intensive PEG-L-asparaginase regimen improves remission rates in ALL

Oct. 16, 2000

Recent patent covers new approach to managing certain side effects of cancer therapy

Oct. 13, 2000

Series of patents issued to Merck for new protein prenyltransferase inhibitors

Oct. 13, 2000

Engineered prostate cancer-specific virus tested in patients with advanced, metastatic disease

Oct. 13, 2000

STI-571 enhances potency of antileukemic therapies against Bcr-Abl-expressing cells

Oct. 13, 2000

Procyon and Biovation enter cancer immunotherapy agreement

Oct. 13, 2000

Antitumor agents patented by Japanese researchers

Oct. 11, 2000

Recent patent covers new inhibitors of specific MMPs

Oct. 11, 2000

Novel target for anticancer therapy and new compounds discovered at Klinge

Oct. 10, 2000